Introduction
Myocardial revascularization is recommended to improve symptoms and clinical outcome, following the latest joint guidelines of the European Society of Cardiology and the European Association of Cardio-thoracic Surgery. 1 Improvement of clinical outcome, in particular, has been associated to the revascularization of the underlying ischemic burden. 2 The latter if not demonstrated by non-invasive functional testing should be confirmed at the time of the diagnostic coronary angiography by the measurement of fractional flow reserve (FFR). FFR, in fact, allows the identification with unequal spatial resolution of the coronary stenosis responsible of reversible ischemia. In addition, percutaneous revascularization performed in the presence of an abnormal FFR (i.e. FFR 0.80) results into an improved clinical outcome as compared with a revascularization strategy guided solely by the angiographic severity of the coronary stenosis. [3] [4] [5] [6] [7] [8] [9] Nevertheless only scarce data supporting the role of FFR in the guidance of surgical revascularization are available. Botman et al. showed a significant relationship between functionally significant coronary stenosis as demonstrated by FFR and graft patency at one year. 10 The aim of our retrospective study is to investigate the impact of FFR measurement at the time of the pre-operative diagnostic coronary angiography on surgical revascularization and its related clinical outcome as compared with conventional angiographic guidance.
Methods

Population
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Patients were divided into 2 groups: angiography-guided (Angio-guided) and FFR-guided groups. The Angio-guided group consisted of patients, where no FFR was measured at the time of the pre-operative coronary angiography, and coronary artery by-pass graft (CABG) was indicated solely on the basis of the angiographic severity of the coronary stenosis. The FFRguided group consisted of patients, in whom at least one intermediate stenosis was measured by FFR, and grafted in the presence of FFR 0.80 or deferred with FFR > 0.80.
Coronary angiography and FFR measurement
Coronary angiography was performed by a standard percutaneous femoral or radial approach with 6 or 7 Fr diagnostic-or guiding catheters. After the administration of 200-300 μg intracoronary isosorbide dinitrate (ISDN), the angiogram was repeated in the projection allowing the best possible visualization of the stenosis. Experienced operators not involved in the analysis of the data assessed stenosis severity. Multivessel disease was defined in the presence of stenosis in 2 or more major coronary arteries.
Performance of FFR measurement was left at the operator's discretion. FFR was measured as previously described. 11, 12 Briefly, a pressure monitoring guide wire (Certus was obtained with either intravenous infusion (140 g/kg/min) or intracoronary bolus (70-100 g) adenosine. An FFR value lower or equal to 0.80 indicated an ischemia-producing coronary stenosis.
Coronary artery bypass surgery
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Type of surgery, namely on-pump or off-pump, number and type of grafts were left to the surgeon's discretion.
Study endpoints
Primary endpoint of the study was the rate of major adverse cardiac events (MACE), defined as overall death, myocardial infarction (MI) and target vessel revascularization (TVR) up to 3 years clinical follow-up. Secondary endpoints were all the individual endpoints included in MACE, plus the number of graft anastomoses, and the symptoms at the last clinical follow-up available.
MI was defined as previously described. 13, 14 TVR was defined as any percutaneous or surgical revascularization performed at the follow-up either to the index study vessel or to the related vascular graft conduit.
In a group of patients undergoing a clinically indicated coronary angiography during the follow-up, graft patency rate was evaluated. Here, a sub-analysis was performed on a graft level.
In particular, in the Angio-guided graft group we included all the grafts implanted on coronary 
Statistical Analysis
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Results
Clinical characteristics
We included 627 patients: 429 in the Angio-guided group, and 198 in the FFR-guided group.
Clinical characteristics are summarized in Table 1 . There were no significant differences in baseline characteristics between the 2 groups except that Angio-guided patients were older, more frequently female and diabetic. FFR-guided patients had more frequently PCI in the past.
Angiographic and surgical characteristics
Rate of multi-vessel disease (MVD) at coronary angiography was similar between the 2 groups Table   2 ). In addition, a lower rate of on-pump surgery was observed in the FFR-guided versus the Angio-guided group (49% vs. 69%, p<0.001), while only a trend was found toward lower pump time in the FFR-guided group.
Clinical follow-up
Clinical follow-up was available in 419 (98%) patients in the Angio-guided group and in 193 
Role of FFR in patients selected to CABG
Myocardial revascularization is recommended when a large territory of reversible myocardial ischemia is present. 1,2 Of note, patients undergoing surgical revascularization usually present with complex coronary artery disease, like left main stenosis or multivessel disease. In these conditions, non-invasive functional testing has demonstrated limited accuracy and poor spatial resolution in detecting reversible ischemia. 15 At the variance, FFR has high spatial resolution as it allows to interrogate each stenotic coronary artery and to unmask possible ischemia-producing stenoses. 16 This was particularly evident in our study. Rate of multivessel disease, in fact, was not significantly different between the 2 groups at baseline angiography. Yet, after FFRmeasurement, rate of multivessel disease was significantly downgraded in patients of the FFRguided group, suggesting that several coronary stenosis deemed angiographically significant turned out to be not ischemia producing at the invasive functional evaluation. 17 A significant independent interaction was found between FFR measurement at the time of the diagnostic coronary angiography and surgical revascularization eventually adopted as confirmed by the inverse relationship found between FFR-guidance and number of anastomoses. As a consequence, the number of grafts and the total number of anastomoses, the venous anastomoses in particular, were significantly reduced in the FFR-guided group. The number of arterial anastomoses was similar between the 2 groups, with a higher arterial-venous anastomosis ratio in the FFR-guided group. In addition, rate of 4 or more anastomoses and on-pump surgery were esolution in detecting reversible ischemia. 15 At the variance, FFR has high spati tial a al r r res esol ol olut ut utio io ion n n as a t allows to interrogate each stenotic coronary artery and to unmask possible ischemia-producing t ten en nos os ose es es. 16 16 16 T T Th h his wa wa was s particularly evident in our st st stud ud dy. Rate of mu ult lt l ives es sse se sel l disease, in fact, was n not s significantl tly y d di iff f fer eren n nt t be be betw tw twee een n n t th the e 2 2 gro oup p ps at t t b b base e eli li ine ne an ng ngio io og gr rap aphy h h . . Ye Ye et, t, , a aft fte e er F F FFR FR FR--me me eas as a ur ur urem emen en ent, t t, r ra at te e of of m m mu ul ulti tive e ess ssel el el d d dis is isea ea ase se e w w wa as a s s sig ig ign n nif fi fica a ant nt tly ly ly d dow ow own ng ngra ra rade de d d d i in in p p pat at atie ie i nt nt ts s s o o of t t the e e F FFR FR FR--guided group up p, , su su ugg gg gges es e ti ti ting ng n t t tha ha hat t t se e eve ve v ra ra ral l co co coro ro rona na nary ry ry st st ten en nos os o is s d d dee ee eeme me med d d an an angi gi giog og ogra ra raph ph phic ical al ally ly ly s s sig ig igni n ficant significantly reduced, with a trend toward a reduced pump time, suggesting overall a less complex surgical protocol performed in the FFR-guided group.
Grafted coronary arteries were equally distributed between the 2 groups with the exception of lower rate of right coronary artery grafted in the FFR-guided group. This is of no surprise if considering that intermediate stenosis of the RCA can be found more frequently with a non-significant FFR value, 18 and can be attributed to the more limited subtended myocardial territory of the RCA as compared with the left coronary artery.
FFR-guided CABG and clinical outcome
An FFR-guided percutaneous revascularization has been associated with a significant clinical benefit into different clinical and anatomical settings compared to a percutaneous revascularization strategy guided solely by the angiographic severity of the coronary stenosis. [3] [4] [5] [6] [7] [8] [9] In addition, deferral of coronary stenosis with non-significant FFR to optimal medical therapy has shown a favorable outcome. 3, 5 In our patients of the FFR-guided group, we did not observe any signal of excess hazards during the follow-up. In addition, patients of the FFR-guided group presented improved symptoms, considering that rate of CCS class II-IV was significantly reduced as compared with patients of the Angio-guided group. This is particularly remarkable if considering that patients of the FFR-guided group underwent a more limited revascularization in terms of anastomoses and grafts implanted. We don't have a definitive explanation for the lower rate of angina in patients of the FFR-guided group. We can only speculate that: 1) on one side, the lack of FFR-guidance might have left some of the functionally significant stenosis un-grafted in patients of the Angio-guided group; 2) on the other side, in patients of the FFR-guided group, the higher arterial to venous anastomosis ratio might have either limited the clinical impact of potential venous graft failure or warranted longer graft patency rate due to the predominance of benefit into different clinical and anatomical settings compared to a percutaneous us s evascularization strategy guided solely by the angiographic severity of the coronary stenosis. [3] [4] [5] [6] [7] [8] [9] n n a a add dd ddit it iti io ion, n, n, d d defer er rra ra ral l of coronary stenosis with non on on-s significant FFR FR R to op op opti ti t mal medical therapy h ha has sh s own a fa favo vo ora abl bl le e e ou ou outc tc tcom om ome. e 3, 3,5 ,5 I I In n n o ou our r pa at tie e ents o of f th h he e FF FF FR R--gu guid ided ed g gro roup up, , , we w we d d did id i n n not ot t o o obs b bser e erv v ve an ny y y si si sign gn gnal al o o of f f ex exc c ces ss ss h haz az zar ards ds d d dur ur rin in ing g g th the e e fo fo foll ll llow ow ow--up up up. I In In a a add dd ddit it iti i ion, n, n, p p pat atie ie ient nt n s s s o of of t th he he F F FFR FR R-g -g -gui i ide de ed d g gr grou ou up p presented im mpr pr prov ov o ed ed ed s sym ym ympt pt tom om oms, , c c con on onsi si s de de eri ri ring ng ng t tha ha hat t r r rat at a e e e of of C C CCS CS CS c c cla la lass s s I I II-I-I IV IV IV w w was as as s sig ig igni ni nifi fi fica ca cantly t t the arterial bypasses. The latter is also suggested by the trend toward an association between arterial anastomoses and CCS class II-IV.
FFR-guided CABG and graft patency
In a prospective registry, Botman et al. showed a significant relationship between functionally significant coronary stenosis as demonstrated by FFR and graft patency at one year. 10 In particular, compared with grafts implanted on stenotic vessels with pathologic FFR, the occlusion rate was nearly 3 times higher in those grafts implanted in stenotic vessels with nonsignificant FFR at the pre-operative coronary angiography. Our findings in the subgroup of patients with angiographic follow-up confirm and further extend to a longer time-period these previous observations. In fact, we found that rate of graft occlusion was 4 times lower in the FFR-guided group up to 3 years follow-up as compared with the Angio-guided group.
Study limitations
Several limitations should be acknowledged in our study. First, this is an observational study limited by its retrospective design. Second, we should acknowledge the wide confidence intervals observed for MACE, reflecting the limited sample size of our study. The sample size that would be needed to limit the 95% confidence interval to approximately 15% corresponds to 3800 patients per group. Although based on these figures, a clinically-driven prospective randomized study would be of difficult performance, we believe our study is valuable in that it provides other surrogate endpoints to design prospective studies: i.e. pump time, number of anastomosis, patency rate of grafts, etc. Third, coronary stenosis severity was not assessed by an independent angiographic core-lab. Likewise, some disease of secondary coronary branches might have not been captured in our analysis. Although this limitation equally affected both groups, we cannot exclude an unbalance in favor of the FFR-guided group: i.e. less severe previous observations. In fact, we found that rate of graft occlusion was 4 times lo lo lowe w w r r in in in t t the he he 
Conclusions
An FFR-guided CABG was associated with lower number of graft anastomoses, with a lower rate of on-pump surgery as compared with Angio-guided CABG. This did not result into a higher event rate up to 36-month follow-up and was associated with lower rate of angina.
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Angio-guided (n=429)
FFR-guided (n=198)
HR (95% CI) p
Death, n (%) 31 (7) 
